MORDECHAI SACKS: Open Payments
NPI 1265890396 · LARCHMONT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,795 in 89 payments from 23 companies in 2025. Trend: 2023 $1,835 · 2024 $1,790 · 2025 $1,795
Food & beverage: $1,795
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $329 |
| ABBVIE INC. | 15 | $281 |
| Amgen Inc. | 12 | $169 |
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $102 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| PFIZER INC. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
Products named: QULIPTA, BREZTRI, Ozempic, DUPIXENT, Rybelsus, OTEZLA, XIFAXAN, JARDIANCE.
Industry payments across NY — which companies pay providers there.
